GILUPI Media
Downloads, Informationen und wichtige Links
MEDIA BEREICH
Aktuelle News, aber auch Videos, Broschüren, Pressemitteilungen, Literatur Referenzen und diverses Download Material stellen wir Ihnen in unserem Media Bereich zur Verfügung. Finden Sie hier umfangreiche Informationen...
Broschüren und Infoblätter
Allgemeine Infobroschüre - Fachpersonal Deutsch
"In vivo Isolierung von zirkulierenden Tumorzellen" Individuelle Diagnostik für innovative Behandlung
Download BroschüreGeneral Information Booklet - Professionals English
"In vivo Isolation of circulating tumor cells" Advancing diagnostics for precision medicine.
Download BookletPublikationen
May, 2021 - In vivo isolation of circulating tumor cells in patients with different stages of prostate cancer
G. Theil et al., DOI: 10.3892/ol.2021.12618
Link PublikationJanuary, 2021 - Recognition of the organ-specific mutations in metastatic breast cancer by circulating tumor cells isolated in vivo
S. Li et al., DOI: 10.4149/neo_2020_200317N275
Link PublikationMay, 2020 - A Multi-Analyte Approach for Improved Sensitivity of Liquid Biopsies in Prostate Cancer
L. Hoffmann et al., DOI: 10.3390/cancers12082247
Link PublikationJune, 2020 - In Vivo Enrichment and Elimination of Circulating Tumor Cells by Using a Black Phosphorus and Antibody Functionalized Intravenous Catheter
D. Wang et al., DOI: 10.1002/advs.202000940
Link PublikationJune, 2020 - In Vivo Detection of CTC and CTC Plakoglobin Status Helps Predict Prognosis in Patients with Metastatic Breast Cancer
N. Xie et al., DOI: 10.1007/s12253-020-00847-7
Link PublikationPresse
March, 18, 2021 - GILUPI and SCIENION announce Collaboration...
...for for the Development of Single-Cell CTC Analysis. Potsdam and Berlin, Germany: GILUPI GmbH and SCIENION AG today announced that the companies intend to intensify their collaboration in the field of single circulating tumor cell (CTC) analysis.
Download PRFebruary, 23, 2021 - GILUPI CellCollector® Technology Selected...
... for Application in Phase I TENDU Study. The GILUPI CellCollector® is the technology of choice for the analysis of circulating tumor cells (CTCs) in a clinical trial just recently started and announced by Norwegian company Ultimovacs ASA.
Download PRSeptember, 19, 2019 - Attendance and Exhibition at the ACTC Conference 2019
The company is a sponsor of the 4th ACTC “Liquid Biopsy: Latest Advances and Future Challenges” meeting. The conference is held in Corfu, Greece from October 2nd to 5th 2019.
Download PRAugust, 12, 2019 - New Publications from multicenter prostate cancer study - TRANSCAN
The blood of cancer patients contains different types of tumor-derived materials that are susceptible to a downstream analysis for example in order to predict therapy response.
Download PRJanuary, 10, 2019 - GILUPI participates in Consortium “European Liquid Biopsies Academy” – ELBA
The research program and educational curriculum of the European Liquid Biopsy Academy - ELBA[1] , a MSCA ITN funded project (GA 765492), educates 15 early stage researchers in a range of applications and disease areas surrounding liquid biopsy
Download PR